Martin S. Auerbach
Papers
1
Total Citations
17
H-Index
1
About
Martin S. Auerbach is a nuclear medicine specialist whose research centers on the intersection of molecular imaging and oncology, with a particular focus on novel PET/CT tracers for cancer detection and staging. His most cited work investigates the incidental detection of elastofibroma dorsi using both 68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with esophageal cancer—a study that underscores his expertise in evaluating emerging radiopharmaceuticals for their diagnostic specificity and potential pitfalls. By systematically comparing the performance of fibroblast activation protein inhibitors (FAPI) against standard FDG imaging, Auerbach contributes to the refinement of non-invasive cancer assessment, helping clinicians distinguish benign from malignant findings. His research, while modest in citation count, addresses a critical need in precision oncology: improving the accuracy of PET/CT interpretation to avoid false positives and unnecessary interventions. Auerbach’s work is particularly valuable for trainees and researchers exploring the clinical translation of FAPI-based imaging, offering practical insights into the nuances of tracer biodistribution and incidental findings. His dedication to advancing molecular imaging techniques positions him as a thoughtful contributor to the evolving landscape of cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1